Mucoadhesive Patches of Salbutamol Sulphate for Unidirectional Buccal Drug Delivery: Development and Evaluation

被引:5
作者
Puratchikody, A. [1 ]
Prasanth, V. V. [2 ]
Mathew, Sam T. [3 ]
Kumar, B. Ashok [4 ]
机构
[1] Anna Univ Technol, Dept Pharmaceut Technol, Tiruchirappalli 620024, Tamil Nadu, India
[2] Gautham Coll Pharm, Dept Pharmaceut, Bangalore 560032, Karnataka, India
[3] Novartis Hlth Care Pvt Ltd, Document Operat Clin, Hyderabad 500072, Andhra Pradesh, India
[4] Jadavpur Univ, Dept Pharmaceut Chem, Kolkata 700032, India
关键词
Buccal drug delivery; higuchi kinetics; korsmeyer-peppas equation; mucoadhesive patches; residence time; salbutamol sulphate; swelling index; 3(2) full factorial designs; IN-VIVO EVALUATION; RELEASE; FORMULATION; BIOADHESIVE; DESIGN; FILMS;
D O I
10.2174/156720111795768004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mucoadhesive buccal patches of Salbutamol Sulphate were prepared using five different polymers (polyvinyl pyrrolidone [PVP]), polyvinyl alcohol [PVA], water soluble chitosan [CHWS], acid soluble chitosan [CHAS], hydroxypropyl methyl cellulose [HPMC]) in various proportions and combinations (CHWS/PVP/HPMC, CHWS/PVA/HPMC, CHAS/PVP/HPMC, and CHAS/PVA/HPMC). A 32 full factorial design was used to design the experiments. A total of 72 patches were prepared. Thickness of the patches ranged between 0.3 +/- 0.003 and 0.6 +/- 0.009 mm. Mass of the patches were in the range of 68.12 +/- 4.6 to 95.52 +/- 5.0 mg. Patches showed increased mass whenever PEG -400 was used as plasticizer. The surface pH of patches were acidic to neutral (pH 4-pH 7). Patches showed satisfactory drug loading efficiency (85% to 97%). Eight formulations (C9, C18, C27, C36, D9, D18, D27 and D36)-which showed high folding endurance-were selected for further characterization. Patches with PEG -400 showed higher swelling index when compared to PG. The residence time of the patches ranged between 115 min and 120 min. Formulation C18 showed the maximum in vitro drug release of 101.4 % over a period of 120 min. Formulations D36 and C36 were best fitted to Higuchi model. The remaining formulations were best fitted to the Korsmeyer-Peppas model. Drug permeation was fast and showed the similar profile as that of the in vitro drug release. Patches were stable, during and at the end of the accelerated stability study.
引用
收藏
页码:416 / 425
页数:10
相关论文
共 32 条
[1]   Is the prevalence of asthma declining? Systematic review of epidemiological studies [J].
Anandan, C. ;
Nurmatov, U. ;
van Schayck, O. C. P. ;
Sheikh, A. .
ALLERGY, 2010, 65 (02) :152-167
[2]  
[Anonymous], 2009, Prescrire Int, V18, P205
[3]  
[Anonymous], 2008, Journal of Pain Palliative Care Pharmacotherapy, V22, P47
[4]   Development of mucoadhesive buccal films for the treatment of oral sub-mucous fibrosis: a preliminary study [J].
Averineni, Ranjith Kumar ;
Sunderajan, Subramanian Ganesa ;
Mutalik, Srinivas ;
Nayak, Usha ;
Shavi, Gopal ;
Armugam, Karthik ;
Meka, Sreenivasa Reddy ;
Pandey, Sureshwar ;
Nayanabhirama, Udupa .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2009, 14 (02) :199-207
[5]   DEVELOPMENT AND TESTING OF BIOADHESIVE, FLUORIDE-CONTAINING SLOW-RELEASE TABLETS FOR ORAL USE [J].
BOTTENBERG, P ;
CLEYMAET, R ;
DEMUYNCK, C ;
REMON, JP ;
COOMANS, D ;
MICHOTTE, Y ;
SLOP, D .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (07) :457-464
[6]   NOVEL CONCEPT FOR A MUCOSAL ADHESIVE OINTMENT [J].
BREMECKER, KD ;
STREMPEL, H ;
KLEIN, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (04) :548-552
[7]   SELECTIVE ACTION OF BETA-ADRENOCEPTOR BLOCKING-DRUGS AND NATURE OF BETA-1 AND BETA-2 ADRENOCEPTORS [J].
COLEMAN, AJ ;
SOMERVILLE, AR .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 59 (01) :83-93
[8]   Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits [J].
Cui, ZR ;
Mumper, RJ .
PHARMACEUTICAL RESEARCH, 2002, 19 (07) :947-953
[9]   THE BETA-2-ADRENOCEPTOR AGONISTS CLENBUTEROL AND SALBUTAMOL ENHANCE THE HYPOTHERMIC ACTION OF 8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN (8-OH-DPAT) IN MICE BY A CENTRAL MECHANISM [J].
GREEN, AR ;
GOODWIN, GM ;
DESOUZA, RJ ;
HEAL, DJ .
NEUROPHARMACOLOGY, 1986, 25 (01) :21-24
[10]  
Haesun P, 1987, PHARM RES, V4, P457, DOI [DOI 10.1023/A:1016467219657, 10.1023/A: 1016467219657]